1,5-Anhydroglucitol: A Novel Biomarker of Adherence to Sodium–Glucose Cotransporter 2 Inhibitors-Reference-Cited by-同舟云学术

1,5-Anhydroglucitol: A Novel Biomarker of Adherence to Sodium–Glucose Cotransporter 2 Inhibitors

Published:2023-12-13 Issue:2 Volume:47 Page:e9-e10
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Daya Natalie R.¹^ORCID,Fang Michael¹,Mathew Mahesh²,Shin Jung-Im¹,Pankow James²,Lutsey Pamela L.²,Valint Arielle³,Echouffo-Tcheugui Justin B.¹⁴,Selvin Elizabeth¹^ORCID

Affiliation:

1. 1Department of Epidemiology and the Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

2. 2Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN

3. 3University of North Carolina Gillings School of Public Health, Chapel Hill, NC

4. 4Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Funder

National Heart, Lung, and Blood Institute

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute on Aging

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/47/2/e9/745759/dc232035.pdf

Reference5 articles.

1. Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control;Yamanouchi;Diabetes Res Clin Pract,1994

2. U.S. Food and Drug Administration . 510(k) Substantial Equivalence Determination Decision Summary. U.S. Food and Drug Administration, 2003. Accessed 15 August 2023. Available from https://www.accessdata.fda.gov/cdrh_docs/reviews/K031604.pdf

3. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions;Dungan;Expert Rev Mol Diagn,2008

4. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body;Yamanouchi;Am J Physiol,1992

5. Effect of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol;Balis;J Diabetes,2014